Liver News and Research

RSS

Early contact with needle-exchange program can have a protective effect against hepatitis C

People who inject drugs and who are female, homeless or amphetamine users often share needles and syringes, and consequently run a higher risk of infection hepatitis C virus infection that affect the liver.

3 Jun 2019

Receiving blood transfusion during liver cancer surgery has higher risk of recurrence and death

Receiving a blood transfusion during curative surgery for the most common type of liver cancer is associated with a much higher risk of cancer recurrence and dying prematurely, according to new research being presented at this year's Euroanaesthesia congress in Vienna, Austria

3 Jun 2019

Oral androgen receptor inhibitor improves outcomes for men with mHSPC

Enzalutamide, an oral androgen receptor inhibitor, can improve outcomes for men with metastatic hormone-sensitive prostate cancer, according to a large study presented by Christopher Sweeney, MBBS of Dana-Farber Cancer Institute's Lank Center for Genitourinary Oncology, during the American Society of Clinical Oncology Annual Meeting.

3 Jun 2019

New targeted therapy using radio waves blocks growth of liver cancer cells, study shows

A new targeted therapy using non-thermal radio waves has been shown to block the growth of liver cancer cells anywhere in the body without damaging healthy cells, according to a study conducted by scientists at Wake Forest School of Medicine, part of Wake Forest Baptist Health.

31 May 2019

Cancer mortality at an all time low finds report

In a new Annual Report to the Nation on the Status of Cancer, researchers have found that death rates due to cancer have declined over among all age groups and both sexes in the United States between 1999 and 2016.

30 May 2019

New studies from UCI shine light on circadian clocks

Can your liver sense when you're staring at a television screen or cellphone late at night? Apparently so, and when such activity is detected, the organ can throw your circadian rhythms out of whack, leaving you more susceptible to health problems.

30 May 2019

Newly discovered mechanism of enzyme links circadian clock and fat metabolism

The enzyme Nocturnin, which governs daily tasks such as fat metabolism and energy usage, works in an entirely different way than previously thought, reported a team of researchers at Princeton University.

30 May 2019

Metabolite of kratom alkaloid could be responsible for its pain relief benefits

Kratom is a Southeast Asian tree with a long history of use in traditional medicine.

30 May 2019

Air pollution associated with high risks for birth defects

A study came from the Texas A&M University researchers that shows that the harmful particulate matter present in the atmosphere due to air pollution could lead to birth defects and even still births during pregnancy.

29 May 2019

New laboratory test has potential to accurately predict spread of breast cancer

Researchers at The Johns Hopkins University and other institutions report that a new laboratory test that induces cancer cells to squeeze through narrow spaces has the potential to accurately predict which breast cancers and other solid tumors are likely to spread, or metastasize, to other sites.

From Johns Hopkins Medicine 29 May 2019

Are DNA-based diets and personalized 'medical foods' the future for weight loss?

Experts say that by understanding how a person responds to specific nutrients, healthcare practitioners could provide better nutritional advice.

28 May 2019

Newly approved gene therapy for SMA is based on delivery vehicle discovered by Penn expert

James Wilson, MD, PhD, recalls being struck by the devastating toll of rare diseases as a young physician in the 1980s. He set out on a path to correct the genes that cause these conditions, including spinal muscle atrophy (SMA), the most common inherited fatal disease in infants.

25 May 2019

Deactivating specific protein with drugs reverses inflammation, scarring of liver in NASH patients

A team of researchers led by Duke-NUS Medical School and National Heart Centre Singapore found that deactivating a specific protein - interleukin 11 - with drugs called therapeutic antibodies, reverses inflammation and scarring of the liver in patients suffering from an untreatable type of fatty liver disease called non-alcoholic steatohepatitis .

25 May 2019